Skip to main content
. 2022 Feb 17;16:712891. doi: 10.3389/fnins.2022.712891

FIGURE 1.

FIGURE 1

(A) The number of DOC patients’ responses to the olfactory and water stimuli. Fourteen showed behavioral responses to the 1-Octen-3-ol stimulus, 10 showed behavioral responses to the pyridine, and 2 showed behavioral responses to the water stimulus. (B) The number of responses for MCS and UWS patients to the 1-Octen-3-ol stimulus. No UWS patients showed a behavioral response to the 1-Octen-3-ol stimulus, and 14 MCS patients showed an obvious behavioral response to the 1-Octen-3-ol stimulus (93.3%). (C) The number of responses for MCS and UWS patients to the pyridine. One UWS patient showed behavioral response to the pyridine (12.5%), and nine MCS patients showed an obvious behavioral response to the pyridine (60%). (D) The number of responses to the 1-Octen-3-ol and pyridine stimuli for MCS patients. Fourteen MCS patients showed an obvious behavioral response to the 1-Octen-3-ol stimulus (93.3%). Nine MCS patients showed an obvious behavioral response to the pyridine (60%). **p < 0.01; ***p < 0.001; ns, no significant difference; black (+), behavioral responses to an olfactory stimulus; gray (–): no behavioral responses to an olfactory stimulus; UWS: unresponsive wakefulness syndrome; MCS, minimally conscious state.